Navigation Links
West Michigan's Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures
Date:11/10/2008

GRAND RAPIDS, Mich., Nov. 10 /PRNewswire/ -- The West Michigan Science & Technology Initiative and EDF Ventures today announced the incorporation and financing of a new medical device company, TransCorp, Inc. TransCorp is temporarily located at the West Michigan Science & Technology offices in Grand Valley State University's Cook-DeVos Center for Health Sciences. The company will work to develop and commercialize novel surgical instruments and implants. Other participants in the financing include the Grand Angels, and Hopen Therapeutics, LLC.

EDF provided the necessary business counsel to take their company to the next level. The Initiative provided the new company with needed office space.

"Mike DeVries at EDF is clearly one of the leading medical device investors in this region," said David Lowry, M.D., TransCorp founder. "Mike knows the medical device space very well, and EDF has a proven track record as a solid investor."

"Supporting innovative companies like TransCorp is a vital component to what we do every day," said Linda Chamberlain, executive director of the West Michigan Science & Technology Initiative. "We are happy that we were able to provide the space they needed to get started and make any connections or collaborate with other clients and tenants to help TransCorp achieve their goals."

TransCorp was co-founded by David Lowry, M.D., a neurosurgeon with the Brain + Spine Center in Holland, Mich., Scott Tuinstra, PA-C, a physician assistant with the Brain + Spine Center, Roger Veldman, associate professor of engineering in the Department of Engineering at Hope College and Des O'Farrell who will serve as president of the new company.

Additionally, Mike DeVries of EDF Ventures and Mark Olesnvage of Hopen Therapeutics have been named to the TransCorp board of directors. DeVries will serve as chairman of the board.

"Mike and the EDF team understand the needs of seed and early stage companies, and they bring a
'/>"/>

SOURCE EDF Ventures
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
2. Gynecologic Oncologist, With Board Certification in GYN Oncology, OB/GYN, and Surgery Offers Women With Cancer the Newest Treatment Frontier: the Surgical Robot
3. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
4. ThirdBiotech Announces Kemeta as Newest Sponsor
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. BioMS Medical announces its intention to renew a normal course issuer bid
10. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
11. ATS Medical Expands Open Pivot Heart Valve Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... and SHANGHAI , Aug. ... biopharmaceutical company developing next-generation antibiotics, today announced positive ... study for its lead drug candidate MRX-I. MRX-I ... drug-resistant bacteria such as MRSA and VRE, while ... tolerated therapeutic option than currently available oxazolidinone agents. ...
(Date:8/31/2015)... STOCKHOLM , Aug. 31, 2015 Trimb ... an agreement to acquire YouMedical Group BV ("YouMedical"), a ... YouMedical has total annual sales of approximately EUR 16 ... categories. "Our ambition is to build ... an important step toward that goal. YouMedical gives us ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment option ... the first commercially available new FDA approved system in the last 14 years, and ... the high Amenorrhea (zero bleeding) rate of 66%, the high Patient Satisfaction rate of ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/zsgg5n/global_and_usa ... & USA BioSimilar Market Analysis to 2021" report ... Biosimilar market will be initiated in September as Sandoz ... the global market react? Will biosimilars explode into the ... the US economy up to $250 billion within the ...
Breaking Biology Technology:MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3
... that Programs to Curb Unsafe Sex and Drug, ... Global AIDS Response, MEXICO CITY, Aug. 5 ... AIDS experts calls on global leaders to aggressively,expand HIV ... and drug use. Citing hundreds of clinical trials and,observational ...
... Quarter 2007, EMERYVILLE, Calif., Aug. 5 Onyx,Pharmaceuticals, ... results,for the three and six months ended June 30, ... per diluted share, for the second quarter of 2008,compared ... per diluted share, in the,same period in 2007. Excluding ...
... ... - Net Loss Continued to Narrow - ... Company Updates 2008 Guidance - ... Health,Inc. (Nasdaq: GHDX ) today reported financial results and business progress,for the quarter ended June 30, 2008., ...
Cached Biology Technology:Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV 2Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV 3Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV 4Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 2Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 3Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 4Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 5Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 6Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 7Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 8Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 9Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 10Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 2Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 3Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 4Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 5Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 6Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 7Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 8Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 9Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 10
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
(Date:8/5/2015)... ALBANY, New York , August 5, 2015 /PRNewswire/ ... new market report titled "Facial Recognition Market - Global ... - 2022", the global market for facial recognition is ... market is driven by increased demand for surveillance systems ... to the rising number of crimes and terrorist activities ...
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. ... interface solutions, today announced that members of the executive ... the Pacific Crest Global Technology Leadership Forum on Tuesday, ... conference will be held at the Sonnenalp Resort in ... The presentation may include forward-looking information. An audio webcast ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
... the regulation of blood stem cells and the complex, ... published in the February issue of Developmental Cell expands ... the role of a key gene known to be ... research will be useful for future studies aimed at ...
... team using a novel genetic cloning and sequencing technique has ... Midwest therapy pool, pointing to the need for closer scrutiny ... by Washington University in St. Louis and involving the University ... new study assessed the microbe population in a warm hospital ...
... studying how external information gets transmitted from outside of ... particular responses. But cell signaling networks are so complex ... , Now, a research team from Stanford, MIT and ... signaling networks quickly and accurately. Their findings appear in ...
Cached Biology News:New insight into regulation of blood stem cells 2New lab technique identifies high levels of pathogens in therapy pool 2New lab technique identifies high levels of pathogens in therapy pool 3Computational Method Speeds Mapping of Cell Signaling Networks 2Computational Method Speeds Mapping of Cell Signaling Networks 3
This STAT antibody sampler pack contains 8 monoclonal ,STAT antibodies....
Request Info...
Invitrogen's Calcium Phosphate Transfection Kit provides high-quality reagents to enable the introduction of DNA into tissue culture cells via calcium phosphate co-precipitation....
Request Info...
Biology Products: